Phase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: clinical and immunological findings

Various studies have emphasized an immunodepression state observed at the tumour site. To reverse this defect and based upon animal studies, we initiated a phase I clinical trial of gene therapy in which various doses of xenogeneic monkey fibroblasts (Vero cells) genetically engineered to produce hu...

Descripción completa

Detalles Bibliográficos
Autores principales: Tartour, E, Mehtali, M, Sastre-Garau, X, Joyeux, I, Mathiot, C, Pleau, J M, Squiban, P, Rochlitz, C, Courtney, M, Jantscheff, P, Herrmann, R, Pouillart, P, Fridman, W H, Dorval, T
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363414/
https://www.ncbi.nlm.nih.gov/pubmed/11076653
http://dx.doi.org/10.1054/bjoc.2000.1492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363414/
https://www.ncbi.nlm.nih.gov/pubmed/11076653
http://dx.doi.org/10.1054/bjoc.2000.1492

Ejemplares similares